通过队列范围免疫表型分析提取自身免疫性风湿病间的免疫学和临床异质性
研究对超过1000例日本11种自身免疫性风湿病(AIRDs)患者进行46种外周免疫细胞的8色流式细胞术免疫表型分析,通过多模态聚类揭示疾病-细胞类型网络及患者亚群;发现类风湿关节炎(RA)样或系统性红斑狼疮(SLE)样集群在AIRDs中占主导,RA患者中SLE样免疫表型与治疗抵抗相关,多基因风险评分(PRS)与临床及免疫特征相关。
要点
- 多模态聚类揭示AIRDs间共享或独特的免疫细胞类型特异性,如混合性结缔组织病与SLE免疫网络接近。
- AIRDs患者可聚类为具有不同免疫特征的亚群,RA样或SLE样集群占主导。
- RA患者中SLE样免疫表型与疾病活动度和治疗反应异质性相关,如治疗抵抗。
核心结论
- 队列范围和跨疾病免疫表型分析阐明了单一疾病内存在的临床异质性患者亚型,以免疫细胞类型特异性方式呈现。
研究设计与样本
- 采用人类免疫学方案进行8色流式细胞术分析46种外周免疫细胞,数据集来自FLOW研究注册的超过1000例日本11种AIRDs患者,包括RA和SLE,具有深度临床信息。
- 对识别的RA患者集群进行深度临床和免疫学表征,包括基于多基因风险评分(PRS)的先天人类遗传学关联分析。
主要发现
- 免疫表型的多模态聚类在免疫细胞、疾病和患者集群分辨率上解析了潜在的疾病-细胞类型网络。
- 患者水平聚类将AIRDs患者分为具有不同免疫特征的多个集群,其中RA样或SLE样集群独占主导,显示AIRDs中RA与SLE的免疫分化。
- RA的深度临床分析显示,患者集群差异定义了疾病活动度和治疗反应的临床异质性,如具有SLE样免疫表型的RA患者出现治疗抵抗。
- 基于RA病例对照和病例内分层全基因组关联研究的PRS与临床和免疫特征相关,指向参与疾病生物学的免疫细胞类型,如树突状细胞与RA-间质性肺病相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases (AIRDs) is essential towards personalised medicine. METHODS: We conducted large-scale and cohort-wide immunophenotyping of 46 peripheral immune cells using Human Immunology Protocol of comprehensive 8-colour flow cytometric analysis. Dataset consisted of >1000 Japanese patients of 11 AIRDs with deep clinical information registered at the FLOW study, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In-depth clinical and immunological characterisation was conducted for the identified RA patient clusters, including associations of inborn human genetics represented by Polygenic Risk Score (PRS). RESULTS: Multimodal clustering of immunophenotypes deciphered underlying disease-cell type network in immune cell, disease and patient cluster resolutions. This provided immune cell type specificity shared or distinct across AIRDs, such as close immunological network between mixed connective tissue disease and SLE. Individual patient-level clustering dissected patients with AIRD into several clusters with different immunological features. Of these, RA-like or SLE-like clusters were exclusively dominant, showing immunological differentiation between RA and SLE across AIRDs. In-depth clinical analysis of RA revealed that such patient clusters differentially defined clinical heterogeneity in disease activity and treatment responses, such as treatment resistance in patients with RA with SLE-like immunophenotypes. PRS based on RA case-control and within-case stratified genome-wide association studies were associated with clinical and immunological characteristics. This pointed immune cell type implicated in disease biology such as dendritic cells for RA-interstitial lung disease. CONCLUSION: Cohort-wide and cross-disease immunophenotyping elucidate clinically heterogeneous patient subtypes existing within single disease in immune cell type-specific manner.
引用
- Tanaka H, Okada Y, Nakayamada S, et al. Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping. Ann Rheum Dis. 2024. PMID: 37903543. doi:10.1136/ard-2023-224537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。